LASA SUPERGENERICS
|
|
BOM : 540702     NSE : LASA     | |
LT :  
    Long Term Analysis
Fundamentals : Bad
Valuation : Bad [Stock is Expensive] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward Pledged Shares : None or < 25% |
Aug 30,2024 |
Price(EOD): ₹ 29.09
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Pharmaceuticals & Drugs |
MCap: ₹ 145.74 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
LASA SUPERGENERICS | 3.1% | 22.1% | 15.1% |
SUN PHARMACEUTICAL INDUSTRIES | 2.7% | 6% | 62.4% |
CIPLA | 3.9% | 7.3% | 33.9% |
DR REDDYS LABORATORIES | 1.2% | 4.2% | 20.1% |
ZYDUS LIFESCIENCES | 1.8% | -9.5% | 80.1% |
DIVIS LABORATORIES | 3.2% | 3.5% | 37.8% |
FUNDAMENTAL ANALYSIS OF LASA SUPERGENERICS
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF LASA SUPERGENERICS
 Ratio | Standalone | |
---|---|---|
P/E P/B P/S |
-7.47
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs -19.51 Cr
[Latest Qtr - Jun2024 - Standalone Results ] 1.23
P/B Calculated based on Book Value of Rs 118.29 Cr
[Latest Year - Mar2023 - Standalone Results ] 1.39
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 0.00 Cr
[Latest Qtr - Jun2024 - Standalone Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
NA 102% 101% |
SHARE PRICE MOMENTUM OF LASA SUPERGENERICS
LASA SUPERGENERICS vs SENSEX
DEBT OF LASA SUPERGENERICS
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2023 2022 2021 Avg_3yrs |
0.18 0.13 0.12 0.14 |
- - - - |
[Last Annual Data : Mar2023]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF LASA SUPERGENERICS
Pledged Promoter Shares |
20.66 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF LASA SUPERGENERICS
Standalone | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
35.15% 145.18% 88.33% 82.14% |
0.92% -55.6% -280.8% 44.8% |
QtrlyTrend |
4 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
LASA SUPERGENERICS related INDICES
You may also like the below Video Courses
FAQ about LASA SUPERGENERICS
Is LASA SUPERGENERICS good for long term investment?
As on Aug 30,2024, the Fundamentals of LASA SUPERGENERICS look Poor and hence it may not be good for long term investment ! See Financial Performance of LASA SUPERGENERICS . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is LASA SUPERGENERICS UnderValued or OverValued?
As on Aug 30,2024, LASA SUPERGENERICS is Over Valued based on the estimates of intrinsic value and hence may not be a good buying opportunity according to Share Valuation at this time!What is the Intrinsic Value of LASA SUPERGENERICS ?
As on Aug 30,2024, the Intrinsic Value of LASA SUPERGENERICS is Rs. 14.45 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. -9.98
Fair Value [Median EV / Sales Model] : Rs. 14.39
Fair Value [Median Price / Sales Model] : Rs. 14.50
Estimated Median Fair Value of LASA SUPERGENERICS : Rs. 14.45
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.